Strolll

Strolll develops wearable AR-assisted glasses for patients with Parkinson's disease, designed to help with mobility, balance training, and gait analysis. The company's technology uses augmented reality visual cues to overcome freezing of gait, a common and debilitating symptom of Parkinson's disease. Founded in 2019 and headquartered in London, United Kingdom, the company has raised approximately $25.6M in Series A funding. Strolll differentiates itself through its targeted approach to neurological rehabilitation, combining AR technology with clinical understanding of Parkinson's disease mechanics. The wearable device provides real-time visual and auditory cues that help patients maintain movement, while also collecting gait data for clinicians to monitor disease progression and treatment efficacy, offering a non-invasive therapeutic option for a condition with limited treatment alternatives.

Augmented Reality > Applications > Healthcare > Digital Therapeutics,

Wearable Technology > Health and Wellness Devices > Neural > Mobility Impairment,

Healthcare IT > Value Based Care > Patient Engagement > Digital Therapeutics > Rehabilitation > VR Based